Co-Authors
This is a "connection" page, showing publications co-authored by Oliver Pfaar and Aziz Sheikh.
Connection Strength
2.497
-
EAACI guidelines on allergen immunotherapy: Executive statement. Allergy. 2018 04; 73(4):739-743.
Score: 0.190
-
Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review. Clin Transl Allergy. 2017; 7:29.
Score: 0.183
-
Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review. Clin Transl Allergy. 2017; 7:30.
Score: 0.183
-
Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2017; 7:32.
Score: 0.183
-
Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy. 2017; 7:24.
Score: 0.182
-
Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews. Clin Transl Allergy. 2017; 7:25.
Score: 0.182
-
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy. 2017 Nov; 72(11):1597-1631.
Score: 0.181
-
Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017 Dec; 72(12):1825-1848.
Score: 0.181
-
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy. 2017 Mar; 72(3):342-365.
Score: 0.175
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021 10; 76(10):2952-2964.
Score: 0.061
-
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19. Int Arch Allergy Immunol. 2021; 182(4):324-338.
Score: 0.058
-
Spices to Control COVID-19 Symptoms: Yes, but Not Only…. Int Arch Allergy Immunol. 2021; 182(6):489-495.
Score: 0.057
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
Score: 0.056
-
Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care? J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2511-2523.
Score: 0.052
-
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol. 2019 07; 144(1):135-143.e6.
Score: 0.051
-
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019; 9:16.
Score: 0.051
-
Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. World Allergy Organ J. 2018; 11(1):15.
Score: 0.049
-
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study. Allergy. 2018 08; 73(8):1622-1631.
Score: 0.048
-
Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study. Allergy. 2018 09; 73(9):1763-1774.
Score: 0.048
-
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project. Allergy. 2018 04; 73(4):816-826.
Score: 0.047
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy. Allergy. 2018 04; 73(4):827-836.
Score: 0.047
-
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018 04; 73(4):744-764.
Score: 0.047
-
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018 04; 73(4):799-815.
Score: 0.047
-
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018 04; 73(4):765-798.
Score: 0.046
-
EAACI guidelines on allergen immunotherapy: Prevention of allergy. Pediatr Allergy Immunol. 2017 Dec; 28(8):728-745.
Score: 0.046
-
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products. Allergy. 2018 Jan; 73(1):64-76.
Score: 0.046